The Food and Drug Administration (FDA) has granted Fast Track designation to 4P004, an intra-articularly administered glucagon-like peptide-1 receptor agonist (GLP-1RA), for the treatment of knee ...
The Well News on MSN
FDA fast tracks access to psychedelics to treat serious mental illness
WASHINGTON - The Food and Drug Administration announced Friday that it will fast track its review of three ...
President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially ...
President Trump has signed an executive order to fast-track psychedelic research and FDA approval, sparking debate among ...
Enolen's fast track designation by the FDA aims to expedite its development for localized prostate cancer treatment, addressing unmet medical needs. The localized delivery technology targets ...
The FDA has granted Regenerative Medicine Advanced Therapy designation to NouvNeu001, a cell therapy for Parkinson’s disease. NouvNeu001, developed by iRegene, is the first allogeneic cell therapy ...
FDA fast tracked ZW191 for platinum-resistant ovarian cancer, aiming to speed development of a potential new option for patients with limited treatments. The U.S. Food and Drug Administration (FDA) ...
The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions. The Food and Drug Administration (FDA) has granted Fast Track ...
ABBV-CLS-628 is currently being evaluated in a phase 2 trial in an estimated 240 adults with ADPKD class 1C, 1D, or 1E. The Food and Drug Administration (FDA) has granted Fast Track designation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results